✦ LIBER ✦

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

✍ Scribed by RE Poupon; KD Lindor; K Cauch-Dudek; ER Dickson; R Poupon; EJ Heathcote

Book ID: 118519870
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 354 KB
Volume: 113
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(97)70183-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined analysis of French, American an

Combined analysis of French, American and Canadian randomized controlled trials of ursodeoxycholic acid therapy in primary biliary cirrhosis

✍ E.J. Heathcote; K.D. Lindor; R. Poupon; K. Cauch-Dudek; E.R. Dickson; R. Trout; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A randomized trial comparing colchicine

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis

✍ R E Poupon; P M Huet; R Poupon; A Bonnand; J T Van Nhieu; E S Zafrani 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2-year controlled study. Seventy-four patients with PBC who had been treated previously with UDCA (at least 8 months) b

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s

Randomised controlled trials of ursodeox

Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis

✍ John Goulis; Gioacchino Leandro; Andrew K Burroughs 📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 101 KB

The canadian multicenter double-blind ra

The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis

✍ E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 969 KB

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h

Ursodeoxycholic acid for primary biliary

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

✍ George V Papatheodoridis; Emilia S Hadziyannis; Melanie Deutsch; Stephanos J Had 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 92 KB